Abiopharma

🔍 Aikawa Yoshiyuki (Director)

Company: SBC Medical Group Holdings Inc (SBC)

Report Date: 2026-04-21

Detailed Transactions and Holdings:

• Sold 3,100,000 shares of Common Stock at $3.0225 per share (Direct)
  Date: 2026-04-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 79,304,460.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-21 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 861,600.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-21 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 5,000,000.00 | Footnotes: F3

Footnotes:

• F1: The price of $3.0225 represents the net price received per share of common stock of SBC Medical Group Holdings Incorporated ("SBC shares"), which were sold by the Reporting Person pursuant to an underwritten public offering that closed on April 21, 2026.
• F2: The 861,600 SBC shares reported as indirectly beneficially owned by the Reporting Person through Aikawa Equity Management Co., Ltd. ("AEM") reflects the Reporting Person's indirect interest that he may be deemed to have shared beneficial ownership over for purposes of Section 16 of the Securities Exchange Act of 1934, as amended. The Reporting Person owns 8,616 shares of AEM, which directly holds 5,284,500 SBC shares, and each share of AEM corresponds to one hundred SBC shares. The Reporting Person does not control AEM, and therefore, disclaims beneficial ownership over the SBC shares held by AEM, except to the extent of his pecuniary interest therein.
• F3: Represents SBC shares held by Aikawa Investment Co., Ltd., a company wholly owned by the Reporting Person, which were previously reported as held by GODO Kaisha Aikawa Investment prior to a change in company form and name change.